Vascular Endothelial Growth Factor Is Associated with the Morphologic and Functional Parameters in Patients with Hypertrophic Cardiomyopathy

Table 1

Patient demographic and clinical characteristics.

	HCM ()
Age (years)	58.4 ± 13.2
Female gender, (%)	6 (28)
Atrial fibrillation, (%)	7 (33)
Creatine level (mol⋅L^−1)	92 ± 14
Diabetes mellitus, (%)	9 (43)
Hyperlipidemia, (%)	14 (66)
Smoking, (%)	7 (33)
NYHA functional class, (%):
I	8 (38)
II	10 (47)
III-IV	3 (14)
Therapy
Medication, (%)
Calcium channel blocker	10 (47)
-blockers	12 (57)
Diuretics	8 (38)
ACE inhibitors/sartans	9 (42)
Implantable devices, (%)
DDD pacing	5 (24)
ICD/BiV	1 (4)

NYHA, New York Heart Association; ACE, angiotensin converting enzyme; DDD, dual chamber pacing; ICD, implantable cardioverter/defibrillator; and BiV, biventricular pacing.